Structure and apoptotic function of p73

BMB Reports

Volumn 48, Issue 2, 2015, Pages 81-90

  Yoon, Mi Kyung ^a   Ha, Ji Hyang ^a   Lee, Min Sung ^a,b   Chi, Seung Wook ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

Apoptosis; Cancer therapy; p53 protein family; p73; Structure

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; DNA BINDING PROTEIN; FAS ANTIGEN; GRAMD4 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; NUCLEAR PROTEIN; PROTEIN P53; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

APOPTOSIS; CELL CYCLE CHECKPOINT; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE CHECKPOINTS; DNA-BINDING PROTEINS; HUMANS; MITOCHONDRIAL PROTEINS; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84925427976     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2015.48.2.255     Document Type: Review

References (61)

1. Dötsch V, Bernassola F, Coutandin D, Candi E and Melino G (2010) p63 and p73, the ancestors of p53. Cold Spring Harb Perspect Biol 2, a004887
2. Cutruzzola F, Avigliano L and Candi E (2014) p73 keeps metabolic control in balance. Cell Cycle 13, 179-180
3. Inoue S, Tomasini R, Rufini A et al (2014) TAp73 is required for spermatogenesis and the maintenance of male fertility. Proc Natl Acad Sci U S A 111, 1843-1848
4. Murray-Zmijewski F, Lane DP and Bourdon JC (2006) p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 13, 962-972
5. Melino G, De Laurenzi V and Vousden KH (2002) p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2, 605-615
6. Munarriz E, Bano D, Sayan AE, Rossi M, Melino G and Nicotera P (2005) Calpain cleavage regulates the protein stability of p73. Biochem Biophys Res Commun 333, 954-960
7. Asher G, Tsvetkov P, Kahana C and Shaul Y (2005) A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev 19, 316-321
8. Rossi M, De Laurenzi V, Munarriz E et al (2005) The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J 24, 836-848
9. Oberst A, Malatesta M, Aqeilan RI et al (2007) The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch. Proc Natl Acad Sci U S A 104, 11280-11285
10. Levy D, Adamovich Y, Reuven N and Shaul Y (2007) The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. Cell Death Differ 14, 743-751
11. Costanzo A, Merlo P, Pediconi N et al (2002) DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol Cell 9, 175-186
12. Mantovani F, Piazza S, Gostissa M et al (2004) Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol Cell 14, 625-636
13. Sayan BS, Yang AL, Conforti F et al (2010) Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2. Proc Natl Acad Sci U S A 107, 12877-12882
14. Toh WH, Siddique MM, Boominathan L, Lin KW and Sabapathy K (2004) c-Jun regulates the stability and activity of the p53 homologue, p73. J Biol Chem 279, 44713-44722
15. Danovi SA, Rossi M, Gudmundsdottir K, Yuan M, Melino G and Basu S (2008) Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ 15, 217-219
16. Dulloo I, Gopalan G, Melino G and Sabapathy K (2010) The antiapoptotic DeltaNp73 is degraded in a c-Jun-dependent manner upon genotoxic stress through the antizyme-mediated pathway. Proc Natl Acad Sci U S A 107, 4902-4907
17. Ramadan S, Terrinoni A, Catani MV et al (2005) p73 induces apoptosis by different mechanisms. Biochem Biophys Res Commun 331, 713-717
18. Zaika AI, Slade N, Erster SH et al (2002) DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 196, 765-780
19. Chi SG, Chang SG, Lee SJ, Lee CH, Kim JI and Park JH (1999) Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer. Cancer Res 59, 2791-2793
20. Moll UM and Slade N (2004) p63 and p73: roles in development and tumor formation. Mol Cancer Res 2, 371-386
21. Casciano I, Mazzocco K, Boni L et al (2002) Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ 9, 246-251
22. Jost CA, Marin MC and Kaelin WG Jr (1997) p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 389, 191-194
23. Miyashita T and Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299
24. Nakano K and Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7, 683-694
25. Oda E, Ohki R, Murasawa H et al (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053-1058
26. Müller M, Wilder S, Bannasch D et al (1998) p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 188, 2033-2045
27. Mihara M, Erster S, Zaika A et al (2003) p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11, 577-590
28. Chipuk JE, Kuwana T, Bouchier-Hayes L et al (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014
29. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD and Green DR (2005) PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309, 1732-1735
30. Chi SW (2014) Structural insights into the transcription-independent apoptotic pathway of p53. BMB Rep 47, 167-172
31. Chipuk JE, Bouchier-Hayes L and Green DR (2006) Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ 13, 1396-1402
32. Ha JH, Shin JS, Yoon MK et al (2013) Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways. J Biol Chem 288, 7387-7398
33. Ha JH, Won EY, Shin JS et al (2011) Molecular mimicry-based repositioning of nutlin-3 to anti-apoptotic Bcl-2 family proteins. J Am Chem Soc 133, 1244-1247
34. Lee DH, Ha JH, Kim Y et al (2014) A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins. Mol Cells 37, 264-269
35. Bell S, Klein C, Muller L, Hansen S and Buchner J (2002) p53 contains large unstructured regions in its native state. J Mol Biol 322, 917-927
36. Burge S, Teufel DP, Townsley FM, Freund SM, Bycroft M, Fersht AR (2009) Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation. Proc Natl Acad Sci U S A 106, 3142-3147
37. Liu G, Xia T and Chen X (2003) The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREBbinding protein. J Biol Chem 278, 17557-17565
38. Shin JS, Ha JH, Lee DH et al (2015) Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition. Cell Cycle 14, 533-543
39. Kussie PH, Gorina S, Marechal V et al (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948-953
40. Canning P, von Delft F and Bullock AN (2012) Structural basis for ASPP2 recognition by the tumor suppressor p73. J Mol Biol 423, 515-527
41. Ethayathulla AS, Tse PW and Monti P (2012) Structure of p73 DNA-binding domain tetramer modulates p73 transactivation. Proc Natl Acad Sci U S A 109, 6066-6071
42. Bullock AN, Henckel J and Fersht AR (2000) Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy. Oncogene 19, 1245-1256
43. Joerger AC, Rajagopalan S, Natan E, Veprintsev DB, Robinson CV and Fersht AR (2009) Structural evolution of p53, p63, and p73: implication for heterotetramer formation. Proc Natl Acad Sci U S A 106, 17705-17710
44. Chi SW, Ayed A and Arrowsmith CH (1999) Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO J 18, 4438-4445
45. Thanos CD, Goodwill KE and Bowie JU (1999) Oligomeric structure of the human EphB2 receptor SAM domain. Science 283, 833-836
46. Stapleton D, Balan I, Pawson T and Sicheri F (1999) The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nat Struct Biol 6, 44-49
47. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ and Green DR (2010) The BCL-2 family reunion. Mol Cell 37, 299-310
48. Melino G, Bernassola F, Ranalli M et al (2004) p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 279, 8076-8083
49. John K, Alla V, Meier C and Pützer BM (2011) GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria. Cell Death Differ 18, 874-886
50. Deng Y and Wu X (2000) Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria. Proc Natl Acad Sci U S A 97, 12050-12055
51. Taebunpakul P, Sayan BS, Flinterman M et al (2012) Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and DeltaNp73 isoforms through ubiquitin ligase PIR2. Apoptosis 17, 762-776
52. Schilling T, Schleithoff ES, Kairat A et al (2009) Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family. Biochem Biophys Res Commun 387, 399-404
53. Terrasson J, Allart S, Martin H et al (2005) p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection. Cancer Res 65, 2787-2794
54. Aqeilan RI, Pekarsky Y, Herrero JJ et al (2004) Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci U S A 101, 4401-4406
55. Inoue T, Stuart J, Leno R and Maki CG (2002) Nuclear import and export signals in control of the p53-related protein p73. J Biol Chem 277, 15053-15060
56. Liu T, Roh SE, Woo JA, Ryu H and Kang DE (2013) Cooperative role of RanBP9 and P73 in mitochondriamediated apoptosis. Cell Death Dis 4, e476
57. Atabakhsh E, Bryce DM, Lefebvre KJ and Schild-Poulter C (2009) RanBPM has proapoptotic activities that regulate cell death pathways in response to DNA damage. Mol Cancer Res 7, 1962-1972
58. Kramer S, Ozaki T, Miyazaki K et al (2005) Protein stability and function of p73 are modulated by a physical interaction with RanBPM in mammalian cultured cells. Oncogene 24, 938-944
59. Rao MA, Cheng H, Quayle AN, Nishitani H, Nelson CC and Rennie PS (2002) RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor. J Biol Chem 277, 48020-48027
60. Sayan AE, Sayan BS, Gogvadze V et al (2008) P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis. Oncogene 27, 4363-4372
61. Chang NS, Pratt N, Heath J et al (2001) Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem 276, 3361-3370